Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia

Clinical Biochemistry

Volumn 38, Issue 2, 2005, Pages 123-127

  Roest, Mark ^a   Jansen, Angelique C M ^b   Barendrecht, Arjan ^a   Leus, Frank R ^a   Kastelein, John J P ^b   Voorbij, Hieronymus A M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Genes; Hypercholesterolemia; Paraoxonase

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENYLACETIC ACID;

ADULT; ARTERY DIAMETER; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE; GENE CONTROL; GENE LOCUS; GENE SEQUENCE; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARAOXANASE GENE; PATIENT; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; THICKNESS;

ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; CAROTID ARTERY DISEASES; EPIDEMIOLOGY, MOLECULAR; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; VARIATION (GENETICS);

EID: 11844267242     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.10.005     Document Type: Article

References (18)

1. M.I. Mackness, B. Mackness, P.N. Durrington, A.M. Fogelman, J. Berliner, and A.J. Lusis Paraoxonase and coronary heart disease Curr. Opin. Lipidol. 9 4 1998 319 324
2. M. Aviram Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases Free Radical Res. 33 2000 S85 S97 [Suppl.]
3. D.M. Shih, Y.R. Xia, X.P. Wang, E. Miller, L.W. Castellani, and G. Subbanagounder Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis J. Biol. Chem. 275 23 2000 17527 17535
4. B. Mackness, G.K. Davies, W. Turkie, E. Lee, D.H. Roberts, and E. Hill Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler. Thromb. Vasc. Biol. 21 9 2001 1451 1457
5. G.P. Jarvik, L.S. Rozek, V.H. Brophy, T.S. Hatsukami, R.J. Richter, and G.D. Schellenberg Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype Arterioscler. Thromb. Vasc. Biol. 20 11 2000 2441 2447
6. B. Mackness, P. Durrington, P. McElduff, J. Yarnell, N. Azam, and M. Watt Low paraoxonase activity predicts coronary events in the Caerphilly prospective study Circulation 107 22 2003 2775 2779
7. H.W. Eckerson, C.M. Wyte, and B.N. La Du The human serum paraoxonase/arylesterase polymorphism Am. J. Hum. Genet. 35 6 1983 1126 1138
8. I. Leviev, F. Negro, and R.W. James Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism Arterioscler. Thromb. Vasc. Biol. 17 11 1997 2935 2939
9. I. Leviev, and R.W. James Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations Arterioscler. Thromb. Vasc. Biol. 20 2 2000 516 521
10. V.H. Brophy, R.L. Jampsa, J.B. Clendenning, L.A. McKinstry, G.P. Jarvik, and C.E. Furlong Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression Am. J. Hum. Genet. 68 6 2001 1428 1436
11. J.G. Wheeler, B.D. Keavney, H. Watkins, R. Collins, and J. Danesh Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies Lancet 363 9410 2004 689 695
12. V.H. Brophy, M.D. Hastings, J.B. Clendenning, R.J. Richter, G.P. Jarvik, and C.E. Furlong Polymorphisms in the human paraoxonase (PON1) promoter Pharmacogenetics 11 1 2001 77 84
13. M.E. Wittekoek, E. de Groot, M.H. Prins, M.D. Trip, H.R. Buller, and J.J. Kastelein Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease Atherosclerosis 146 2 1999 271 279
14. T.J. Smilde, S. van Wissen, H. Wollersheim, M.D. Trip, J.J. Kastelein, and A.F. Stalenhoef Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial Lancet 357 9256 2001 577 581
15. F.R. Leus, M.E. Wittekoek, J. Prins, J.J. Kastelein, and H.A. Voorbij Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia Atherosclerosis 149 2 2000 371 377
16. T. Suehiro, T. Nakamura, M. Inoue, T. Shiinoki, Y. Ikeda, and Y. Kumon A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression Atherosclerosis 150 2 2000 295 298
17. S. Adkins, K.N. Gan, M. Mody, and B.N. La Du Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes Am. J. Hum. Genet. 52 3 1993 598 608
18. R. Humbert, D.A. Adler, C.M. Disteche, C. Hassett, C.J. Omiecinski, and C.E. Furlong The molecular basis of the human serum paraoxonase activity polymorphism Nat. Genet. 3 1 1993 73 76